Skip to main content

Table 2 Significant profiles selected by BSM

From: Modelling gene expression profiles related to prostate tumor progression using binary states

Profile Genes % Folds pValue qValue Type
−1.-1.-1.1 10 4.7 110 4.55E-06 0.09129 Oncogene (Late)
−1.-1.1.1 1 0.5 Inf 0.00E+00 0.00100 Oncogene
−1.0.-1.1 2 0.9 10 1.01E-05 0.19985 Oncogene
−1.0.1.-1 25 11.6 1563 8.00E-07 0.01693 2 t
−1.0.1.0 29 13.5 199 7.30E-06 0.14565 Oncogene
−1.0.1.1 6 2.8 600 5.00E-07 0.01096 Oncogene
−1.1.0.1 2 0.9 42 2.40E-06 0.04871 Oncogene (Early)
−1.1.1.-1 13 6.0 Inf 0.00E+00 0.00100 2 t
−1.1.1.0 20 9.3 3333 3.00E-07 0.00699 Oncogene (Early)
−1.1.1.1 6 2.8 6000 5.00E-08 0.00200 Oncogene (Early)
1.-1.-1.-1 6 2.8 6000 5.00E-08 0.00200 TSG (Early)
1.-1.-1.0 16 7.4 2000 4.00E-07 0.00898 TSG (Early)
1.-1.-1.1 8 3.7 Inf 0.00E+00 0.00100 2 t
1.-1.0.-1 6 2.8 222 1.35E-06 0.02784 TSG (Early)
1.0.-1.-1 5 2.3 625 4.00E-07 0.00898 TSG
1.0.-1.0 19 8.8 184 5.15E-06 0.10314 TSG
1.0.-1.1 6 2.8 231 1.30E-06 0.02686 2 t
1.1.1.-1 35 16.3 412 4.25E-06 0.08548 TSG (Late) / MSG
  1. Folds is the number of times the corresponding stage-state profile was observed in Tomlins dataset relative to the permuted dataset or “Inf” when not observed in permuted dataset.